Sort
130,381 grants matching “hiv”
Development of Vaccines to Prevent Tuberculosis
$1,847,416Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Innate Immunity: Elucidation/Modulation - Cancer Therapy
$1,847,245Ohio State University · P01 · FY2002 · CA
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics
$1,846,892Walther H Mothes · University Of Utah · U54 · FY2024 · AI
CBA (HIV) PREVENTION SERVICES FOR RACIAL/ETHNIC MINORITY POPULATIONS
$1,846,830Debra Olesen · John Snow, Inc. · U65 · FY2006 · PS
CoVPN Cross-Protocol Analyses
$1,846,794Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Recombinant Virus Vaccines
$1,846,692Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
$1,846,691Zhi-Ming Zheng · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Penn PET Addiction Center of Excellence (Penn PACE)
$1,846,343Robert H Mach · University Of Pennsylvania · P30 · FY2021 · DA
Innate Immunity: Elucidation/Modulation - Cancer Therapy
$1,846,087Ohio State University · P01 · FY2003 · CA
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
$1,845,350Zhi-Ming Zheng · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
CURE CTU
$1,845,017Stephen A Spector · University Of California, San Diego · UM1 · FY2025 · AI
ALCOHOL, HIV INFECTION AND HOST DEFENSE
$1,845,000Steve Nelson · Lsu Health Sciences Center · P60 · FY2009 · AA
Modulating the Impact of Critical Events in Early HIV Infection: Effect of Early ART Initiation and Alcohol Use
$1,844,857Ann C Duerr · Fred Hutchinson Cancer Research Center · R01 · FY2017 · DA
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
$1,844,691Barton F Haynes · Duke University · U19 · FY2019 · AI
University of North Carolina Womens Interagency HIV Study UNC WIHS
$1,844,451Adaora A Adimora · Univ Of North Carolina Chapel Hill · U01 · FY2014 · AI
PEER TO PEER CAPACITY BUILDING OF MINISTRIES OF HEALTH IN PUBLIC SECTOR HIV PROGR
$1,844,114Lucy Slater · National Alliance/St & Terr Aids Dirctrs · U2G · FY2012 · PS
NIAID Preclinical Development Support - Production of Research Cell Lines
$1,844,050Jon Carl Mirsalis · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI
HIV PREVENTION TRIALS UNIT-THAILAND
$1,844,040Johns Hopkins University · U01 · FY2004 · AI
Alphavirus Replicon Vaccines against Marburg Virus
$1,843,827Alphavax Human Vaccines, Inc. · U01 · FY2004 · AI
Fully human recombinant therapeutic anti-vaccinia virus polyclonal antibody
$1,843,539Soren Bregenholt · Symphogen A/S · U01 · FY2007 · AI
Adjuvant Discovery for Vaccines against Influenza Virus
$1,843,527Ofer Levy · Boston Children'S Hospital · N01 · FY2017 · AI
CBA (HIV) PREVENTION SERVICES FOR RACIAL/ETHNIC MINORITY POPULATIONS
$1,843,380Debra Olesen · John Snow, Inc. · U65 · FY2007 · PS
Penn PET Addiction Center of Excellence (Penn PACE)
$1,843,247Robert H Mach · University Of Pennsylvania · P30 · FY2022 · DA
ADULT AIDS CLINICAL TRIAL UNIT
$1,842,655University Of Texas Medical Br Galveston · U01 · FY2001 · AI
Providence/Boston Center for AIDS Research (CFAR)
$1,842,213Curt G Beckwith · Miriam Hospital · P30 · FY2025 · AI